Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Cristobal De la Coba"'
Autor:
Natalia Valerievna Zakharova, Adrian G. McNicholl, Maria G. Donday, Nuria Fernandez Moreno, Alfredo J. Lucendo, Horacio Alonso-Galan, Oleg Zaytsev, Rafael Ruíz-Zorrilla López, S A Alekseenko, Jesús Barrio, Javier P. Gisbert, Pedro L. Gonzalez-Cordero, Manuel Castro Fernández, Francis Mégraud, Olga P Nyssen, O. Nunez, Aiman Silkanovna Sarsenbaeva, Ines Modolell, Liudmila Vologzhanina, Colm O'Morain, Oleg Shvetz, Irina Voynovan, José Luis Domínguez-Jiménez, Maria Caldas, Jorge Pérez Lasala, Galina Dmitrivna Fadeenko, Jen Hinojosa, Ángeles Pérez-Aisa, Pilar Varela, Tatiana Ilchishina, Dmitry S. Bordin, Luis Bujanda, Javier Molina-Infante, Javier Alcedo, Cristobal De la Coba, Inmaculada Santaella
Publikováno v:
Clinical Gastroenterology and Hepatology. 18:89-98
Background & Aims Due to the poor eradication rates of standard triple therapy, the addition of bismuth salts has been proposed for first-line eradication of Helicobacter pylori. We assessed the effectiveness and safety of the combination of bismuth
Autor:
Manuel J. Castro, Jesus Barrio, Tommaso Di Maira, Javier P. Gisbert, Pilar Varela, Francis Mégraud, Judith Gomez-Camarero, Noelia Alcaide, Ariadna Figuerola, Manuel Domínguez-Cajal, Liliana Pozzati, Luis Fernández-Salazar, Nuria Fernández, Colm O'Morain, Pilar Mata Romero, Jenifer Hinojosa, Luis Bujanda, Llúcia Titó, Luis Ferrer, Javier Molina-Infante, Luis Rodrigo, Diego Burgos, Ángeles Pérez-Aisa, Elena Resina, Ignasi Puig, José María Huguet, Cristobal De la Coba, Juan Ortuño, Barbara Gomez, Monica Perona, Olga P Nyssen, Ana Garre, Ines Modollel, Alfredo J. Lucendo, Maria Caldas, Xavier Calvet, Blas Jose Gómez Rodríguez, Manuel Jimenez-Moreno
Publikováno v:
Helicobacter. 25
Background Different bismuth quadruple therapies containing proton-pump inhibitors, bismuth salts, metronidazole, and a tetracycline have been recommended as third-line Helicobacter pylori eradication treatment after failure with clarithromycin and l
Autor:
Olga P, Nyssen, Angeles, Perez-Aisa, Luis, Rodrigo, Manuel, Castro, Pilar, Mata Romero, Juan, Ortuño, Jesus, Barrio, Jose Maria, Huguet, Ines, Modollel, Noelia, Alcaide, Alfredo, Lucendo, Xavier, Calvet, Monica, Perona, Barbara, Gomez, Blas Jose, Gomez Rodriguez, Pilar, Varela, Manuel, Jimenez-Moreno, Manuel, Dominguez-Cajal, Liliana, Pozzati, Diego, Burgos, Luis, Bujanda, Jenifer, Hinojosa, Javier, Molina-Infante, Tommaso, Di Maira, Luis, Ferrer, Luis, Fernández-Salazar, Ariadna, Figuerola, Llucia, Tito, Cristobal, de la Coba, Judith, Gomez-Camarero, Nuria, Fernandez, Maria, Caldas, Ana, Garre, Elena, Resina, Ignasi, Puig, Colm, O'Morain, Francis, Megraud, Javier P, Gisbert
Publikováno v:
HelicobacterREFERENCES. 25(5)
Different bismuth quadruple therapies containing proton-pump inhibitors, bismuth salts, metronidazole, and a tetracycline have been recommended as third-line Helicobacter pylori eradication treatment after failure with clarithromycin and levofloxacin
Autor:
J L Pérez-Calle, David Busquets, Marta Calvo, Fernando Muñoz, Cristobal De la Coba, Ángel Ponferrada, Ignacio Fernández-Blanco, David Olivares, Cristina Alba, María Chaparro, Xavier Calvet, Carlos Taxonera, Manuel Barreiro-de Acosta, R. Pajares, Eva Iglesias, Antonio Rodríguez, Fernando Bermejo, Pilar López-Serrano, Javier P. Gisbert
Publikováno v:
Digestive Diseases and Sciences. 62:481-490
The impact of prior anti-TNF use on “real-life” outcomes of adalimumab therapy in ulcerative colitis (UC) is not well known. To compare the influence of prior anti-TNF use on the outcomes of adalimumab maintenance treatment in UC patients. We als
Autor:
Enrique, Rodríguez de Santiago, Carlos, Martín de Argila de Prados, Hector Miguel, Marcos Prieto, Miguel Ãngel, Jorge Turrión, Eva, Barreiro Alonso, Alvaro, Flores de Miguel, Cristobal, de la Coba Ortiz, Carlos, Rodríguez Escaja, Gustavo, Pérez Álvarez, Carlos, Ferre Aracil, Lara, Aguilera Castro, Ana, García García de Paredes, Antonio, Rodríguez Pérez, Agustin, Albillos Martínez
Publikováno v:
Helicobacter. 22(5)
Helicobacter pylori antibiotic resistance is an increasing problem worldwide. PyleraTo assess the effectiveness, safety, and tolerance of PyleraThis was a multicenter, observational, prospective database study in four Spanish hospitals. Consecutive H
Autor:
L Fernández, Jesús Barrio, María Dolores Aguilar, Ruth de Francisco, Fernando Muñoz, Cristina Saro, Cristobal De la Coba, Pablo Lázaro, Mariola Hernández, Valle García-Sánchez, D Ceballos, Manuel Barreiro-de Acosta
Publikováno v:
Revista Española de Enfermedades Digestivas v.109 n.2 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Española de Enfermedades Digestivas, Volume: 109, Issue: 2, Pages: 122-129, Published: FEB 2017
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 2, Pp 122-129
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Española de Enfermedades Digestivas, Volume: 109, Issue: 2, Pages: 122-129, Published: FEB 2017
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 2, Pp 122-129
Objective: Clinical trials have shown the efficacy of adalimumab in Crohn’s disease, but the outcome in regular practice remains unknown. The aim of the study was to examine clinical status, quality of life, and work productivity of Crohn’s disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfba5ead4bc4e54d36567dea3ac118d7
https://hdl.handle.net/10668/10716
https://hdl.handle.net/10668/10716
Autor:
Cristobal De la Coba, Ángeles Pérez-Aisa, Robin Rivera, Santos Santolaria, Jose M. Viver-Pi-Sunyer, Begoña González, Jesús Barrio, Beatriz Gras-Miralles, Julio Valle, Javier P. Gisbert, Beatriz Madrigal, Fernando Gomollón, Adrian G. McNicholl, Carlos Esteban, Fernando Fernández-Bañares, Felipe Bory, Maria Esteve, C Loras, Mercè Rosinach, Montserrat Forné
Publikováno v:
European Journal of Gastroenterology & Hepatology
Background It has been suggested that GastroPanel might be a useful tool for the diagnosis of chronic atrophic gastritis (CAG) measuring four biomarkers in blood: basal gastrin-17 (G17), pepsinogen I and II (PGI and PGII), and Helicobacter pylori ant
Autor:
Adrian G, McNicholl, Alicia C, Marin, Javier, Molina-Infante, Manuel, Castro, Jesús, Barrio, Julio, Ducons, Xavier, Calvet, Cristobal, de la Coba, Miguel, Montoro, Felipe, Bory, Angeles, Perez-Aisa, Montserrat, Forné, Javier P, Gisbert, Francisco, Abad-Santos
Publikováno v:
Gut. 63(2)
Objectives No trial has compared non-bismuth quadruple ‘sequential’ and ‘concomitant’ regimens in settings with increasing clarithromycin rates. The study aims to compare the effectiveness and safety of these therapies for Helicobacter pylori
Autor:
J. Gomez, Juan Ortuño, Joaquín Hinojosa, Manuel Castro-Fernandez, Angel Lanas, Maria Caldas, Colm O'Morain, Luis Bujanda, Jorge Perez-Lasala, Josep M. Botargues, Monica Perona, Pedro Almela, Alfredo J. Lucendo, Manuel Rodríguez-Téllez, R. Pajares, Luis Fernández Salazar, F Bermejo, Manuel Domínguez-Cajal, Javier Alcedo, Luis Ferrer Barceló, José María Huguet, Cristobal De la Coba, Javier Molina-Infante, Javier P. Gisbert, Rafael Ruiz-Zorrilla, Enrique Medina, Ines Modolell, Jesus Barrio, Angeles Perez Aisa, Mercedes Ramas, Blas-Jose Gomez-Rodriguez, Liliana Pozzati, Adrian G. McNicholl, Luis Rodrigo, Mercè Barenys
Publikováno v:
Gastroenterology. 150:S877
Autor:
Xavier Calvet, Antonio Rodríguez, Javier P. Gisbert, Cristina Alba, María Chaparro, Cristobal De la Coba, Ignacio Fernández-Blanco, David Olivares, Carlos Taxonera, Fernando Bermejo, Manuel Barreiro-de Acosta, José Lázaro Pérez-Calle, David Busquets, Eva Iglesias Flores, Pilar López-Serrano, A. Díaz, R. Pajares, Fernando Muñoz, Marta Calvo
Publikováno v:
Gastroenterology. 148:S-789
Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis Carlos Taxonera, Eva Iglesias Flores, Fernando Munoz, Marta Calvo, Manuel Barreiro-de Acosta, David Busquets, Xavier Calvet, Antonio Rodriguez, R. Pajares, Ja